|
Pinana JL, Heras I, Aiello TF, Garcia-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, Garcia-Vidal C, Arroyo I, Soler-Espejo E, Lopez-Corral L, Avendano-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernandez-Medina L, Gonzalez-Santillana C, Morell J, Hernandez-Rivas JA, Rodriguez-Galvez P, Mico-Cerda M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PubMed PMID: 37896843; PubMed Central PMCID: PMC10612015.
AÑO: 2023; IF: 3.8
|
37896843
|
Bailen R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Valles A, Esquirol A, Fonseca M, Solan L, Sanchez-Vadillo I, Bautista G, Bento L, Lopez-Godino O, Perez-Martinez A, Torrent A, Zanabili J, Calbacho M, Moreno MA, Pascual-Cascon MJ, Guerra-Dominguez L, Chinea A, Garcia-Cadenas I, Lopez-Corral L, Boix-Giner F, Lopez Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernandez-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PubMed PMID: 37304258; PubMed Central PMCID: PMC10250708.
AÑO: 2023; IF: 5.7
|
|
Ljungman P, Tridello G, Pinana JL, Ciceri F, Sengeloev H, Kulagin A, Mielke S, Yegin ZA, Collin M, Einardottir S, Lepretre SD, Maertens J, Campos A, Metafuni E, Pichler H, Folber F, Solano C, Nicholson E, Yuksel MK, Carlson K, Aguado B, Besley C, Byrne J, Heras I, Dignan F, Kroger N, Robin C, Khan A, Lenhoff S, Grassi A, Dobsinska V, Miranda N, Jimenez MJ, Yonal-Hindilerden I, Wilson K, Averbuch D, Cesaro S, Xhaard A, Knelange N, Styczynski J, Mikulska M, de la Camara R. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol. 2023 Mar 7;14:1125824. doi: 10.3389/fimmu.2023.1125824. eCollection 2023. PubMed PMID: 36960069; PubMed Central PMCID: PMC10028143.
AÑO: 2023; IF: 5.7
|
|
Bailen R, Pascual-Cascon MJ, Guerreiro M, Lopez-Corral L, Chinea A, Bermudez A, Sampol A, Heras I, Garcia-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, Lopez-Godino O, Martin-Calvo C, Fernandez-Caldas P, Marcos-Jubilar M, Sanchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Diez-Martin JL, Kwon M; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH). Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. PubMed PMID: 35108627.
AÑO: 2022; IF: 3.2
|
|
Amat P, Lopez-Corral L, Goterris R, Perez A, Lopez O, Heras I, Arbona C, Viguria MC, Hernandez-Boluda JC, Martinez-Ruiz F, Martinez A, Solano C. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant. J Clin Apher. 2021 Oct;36(5):697-710. doi: 10.1002/jca.21918. Epub 2021 Jun 29. PubMed PMID: 34185332.
AÑO: 2021; IF: 2.605
|